Indeed, one possibility is that MCL cells derived from lymph nodes could maintain ex vivo the BCR activity induced by tumor microenvironment in vivo, thus being more similar to the stimulated condition of MCL cells in our study. The gene discussed is BCR; the disease is mantle cell lymphoma.